Addex Therapeutics Price Chart
Addex Therapeutics Volume Chart
Addex Therapeutics Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
+0.19(+2.85%)
| Open | $6.81 |
|---|---|
| Close | $7.00 |
| Low | $6.81 |
| Low Change | 0.00 (0.00%) |
| High | $7.00 |
| High Change | +0.19 (+2.85%) |
| Range | $0.19 |
| Volume | 754 |
| Dollar Volume | $5.28K |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.01(+0.15%)
| Open | $6.82 |
|---|---|
| Close | $6.83 |
| Low | $6.52 |
| Low Change | -0.30 (-4.40%) |
| High | $6.93 |
| High Change | +0.11 (+1.61%) |
| Range | $0.41 |
| Volume | 1.399K |
| Dollar Volume | $9.56K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $6.76 |
|---|---|
| Close | $6.76 |
| Low | $6.76 |
| Low Change | 0.00 (0.00%) |
| High | $6.76 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 184 |
| Dollar Volume | $1.24K |
Addex Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $6.81 |
|---|---|
| 10 Day Moving Average (SMA10) | $6.86 |
| 20 Day Moving Average (SMA20) | $6.83 |
| 50 Day Moving Average (SMA50) | $6.67 |
| 100 Day Moving Average (SMA100) | $7.26 |
| 200 Day Moving Average (SMA200) | $8.00 |
Addex Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Addex Therapeutics Stock Splits
There has been 1 stock split for Addex Therapeutics (ADXN). The reverse stock split occured on October 23, 2023 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Oct 23, 2023 | Reverse | 20:1 |
Addex Therapeutics Dividends
There have been no dividends for Addex Therapeutics (ADXN).